Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51.
Zhang J, Wu D, He Y, Li L, Liu S, Lu J, Gui H, Wang Y, Tao Y, Wang H, Kaushik D, Rodriguez R, Wang Z.
Zhang J, et al. Among authors: gui h.
Biochem Biophys Rep. 2020 Jul 16;23:100778. doi: 10.1016/j.bbrep.2020.100778. eCollection 2020 Sep.
Biochem Biophys Rep. 2020.
PMID: 32695889
Free PMC article.